Select another language
Select another language

About Us

Justin Stindt Consultants is a consulting firm specializing in Strategy & Market Access advisory services for the pharmaceutical, biotech and medical device industries.

Our agency is passionate about enabling patient access to innovative medicines and technologies. We are a service provider to pharma, biotech, medtech and e-health clients, helping to determine what clinical evidence payers will need to see in order to grant reimbursement at a sustainable price. Our team of experts leverages secondary research e.g. in Pricing & Reimbursement databases, primary research with payers and clinical experts and our agency’s experience from hundreds of Market Access projects.

Our agency has extensive international experience in all major EU markets, the US, Japan and selected emerging markets. Our team of experts operates from offices in Paris, Cologne and Zug and has a global reach through our network of payers, clinical experts and partners.

Would you like to know what our customers are saying about us? Then have a look at our client testimonials and you will find attributes such as commitment to excellence, trusted partnerships, flexible and customized support, expert knowledge and our extensive network all engaged to enable Market Access for our client’s products. 

Meet selected experts within our global team

Justin Stindt Consultants mobilizes project teams of 50+ consultants

Justin Stindt

Justin Stindt

Founder and Managing Director

Justin is an experienced Market Access strategist with a background at GlaxoSmithKline and in consulting. Justin supports pharma, biotech and medtech clients with Market Access strategy and execution. He has led hundreds of Pricing & Reimbursement projects, overseen development of Pricing & Reimbursement dossiers, led engagements with HTA bodies and conducted price negotiations on behalf of clients. Justin is fluent in English, French, German, and Spanish.

Javier Arribas Díaz

Javier Arribas Díaz

Director

With a focus on orphan drugs, Javier is experienced in advising pharmaceutical and medtech clients on market access and pricing strategies. Javier is both leading global projects and activities focused on the Spanish market such as the development of Spanish Pricing & Reimbursement strategies and dossiers. Javier has prior consulting experience at Accenture and Werfen. He studied at Kellogg School of Management in the US, did an MBA at IESE in Spain, and is proficient in Spanish and English.

Anne Stindt

Anne Stindt

Director

Anne is a health insurance specialist with a background in digital marketing and health and medical insurance purchasing at AXA where she held roles both on corporate level in the headquarter in Paris and on affiliate level in Germany. At Justin Stindt Consultants, she leads global research projects and develops Pricing & Reimbursement strategies. She is fluent in French, English, German and Portuguese and holds a Master’s degree from ESCP-EAP Business School.

Nicolas Dormois

Business Development Director

Nicolas is specialized in international commercial strategy and has experience in several Marketing & Sales roles in the industry. He is spearheading global commercial expansion as the Director of Business Development at Justin Stindt Consulting. Educated at EDHEC Business School, he brings a global business background and particular flair identifying growth opportunities. Nicolas’ role at JSC is pivotal in fostering relationships with pharma, biotech and Medtech companies worldwide and supporting them with commercial & sales strategy.

Eva Brčić

Eva Brčić

Consultant

Eva specializes in strategic market access research for pharmaceutical and biotech firms. Her projects include pricing and reimbursement analysis, research in medical information and Pricing & Reimbursement databases, and expert interviews with payers and clinical experts. Eva is fluent in English, French, and Croatian and has a Master in Management and a Bachelor’s in Psychology from the Erasmus University Rotterdam.

Camille Maréchal

Camille Maréchal

Consultant

Camille focuses on pricing and reimbursement strategies for pharmaceutical and biotech firms. Her recent projects focused e.g. on early access programs, EU-5 rebate structures and taxation systems. She also contributed to G-BA scientific advice meetings, analyzed real-world evidence interviews, and aided in lifecycle strategy development. Camille, fluent in French, Dutch, German, English and Spanish, holds a Bachelor’s degree in Business Administration from the University of St. Gallen (HSG).

Connect with our team

Our experienced Market Access specialists are just a click away

Our Clients